Cardio-oncology study

Not Applicable

• Conditions: Circulatory System; Anthracycline therapy related cardiac dysfunction; Cardiology

• Registration Number: PACTR201804003218439

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-03-19
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

age: 18 to 50 years
Cancer patients who received anthracycline therapy and developed subclinical ATRCD during follow up

Exclusion Criteria

Patient who is taking carvedilol
Patient who has any of the conditions:HT,DM,CKD,CAD
Patient who has low LVEF

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevention of the worsening of GLS(global longitudinal strain)

Secondary Outcome Measures

Name	Time	Method
Reduce the level of oxidative stress